23 client engagements 25 countries July 2009 insights from Duncan Bucknell Company from duncanbucknell.com Firstly, thanks to our clients who involved us in 23 exciting engagements across around 25 countries in July 2009. Clients we worked with this month were based across the usual North America, Europe, India and ...
Share via E–mail | Twitter | Facebook
ACI Maximizing Pharmaceutical Patent Lifecycles Conference from www.patentdocs.org American Conference Institute (ACI) will be holding its 10th Maximizing Pharmaceutical Patent Lifecycles on October 7-8, 2009 in New York, NY. The conference will allow attendees to: • See how a new global legal paradigm for ...
Share via E–mail | Twitter | Facebook
IP Dispute Could Threaten Skype from www.ip-watch.org Online auction site eBay, the owner of popular, proprietary voice-over-internet protocol software Skype, has warned that the service might not continue if it loses an intellectual property dispute with Joltid, the company from which it ...
Share via E–mail | Twitter | Facebook
BU grad student hit for $875K for illegal downloads from ipbiz.blogspot.com In a case heard before a jury and presided over by U.S. District Judge Nancy Gertner in D Mass, Boston University grad student Joel Tenenbaum was ordered to pay $875,000 for illegal downloading ...
Share via E–mail | Twitter | Facebook
The patent world of iPS (stem cells): Yamanaka, Bayer, and iZumi from ipbiz.blogspot.com Note to californiastemcellreport:
A question a California taxpayer might ask is "how" has CIRM improved the life of average folks in California? You seem to say financing (ie spending money) and training are justifications. What ... Share via E–mail | Twitter | Facebook
Court: Yellow Beans Are Just Yellow Beans from www.patentbaristas.com In a combined proceeding in which a third person sought re-examination of an issued patent (Re-examination No. 90/005,892) and the patentee sought re-issue of the patent to broaden the claims, the United States ...
Share via E–mail | Twitter | Facebook
The Fate of the Rosiglitazone Patents: Far From Rosy? from spicyipindia.blogspot.com Recently, a colleague of mine asserted that till date, GSK had obtained only one pharmaceutical product patent in India! Given that GSK has the largest sales in India (of all the MNC's operating within ...
Share via E–mail | Twitter | Facebook